Lipocine Inc.
LPCN· Nasdaq
Released May 9, 2022, before the open
10-Q filed May 9, 2022, 39 days after period end · 0001493152-22-012445
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Revenue | — | — | — | $0.00 |
| Net Income | -$3.49M | -$3.37M | -$5.77M | -$3.22M |
| EPS Diluted | -$0.04 | -$0.04 |
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR
| -$0.14 |
| -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.